The outspoken investment banker is the chairman of PolyNovo. The burns treatment company’s chief executive is leaving after a ...

Australian biotech company PolyNovo said on Tuesday it has removed its CEO after discussions with the executive last week following media allegations about bullying by the firm's chairman directed at ...

PolyNovo (ASX:PNV) has announced that its chief executive officer, Swami Raote, will officially leave the company in June but ...

PolyNovo (PNV), a burns treatment company, has announced the immediate departure of its chief executive officer, Swami Raote.

Polynovo says CEO Swami Raote has ceased to hold that role, following accusations of corporate governance failings levelled ...

No-moat Polynovo’s PNV CEO has stepped down following reports of certain interactions between the chairman, David Williams, ...

Raote will remain employed until June 10, 2025, but non-executive director Robyn Elliott will take over as acting CEO while ...

Polynovo’s strategy revolves around expanding its geographical footprint to increase access to its products and open new hospital accounts. With its geographical reach the firm estimates its ...

These shares are having a difficult time on Tuesday. But why? The post Why Brickworks, Nickel Industries, Polynovo, and ...

This ASX 200 healthcare share is catching the eye today after making a big announcement. Here's what you need to ...

Shares in biotech PolyNovo dived like a German Stuka on Friday – down 13 per cent – after management finally fessed up to ...

Despite announcing strong earnings, PolyNovo Limited's ( ASX:PNV ) stock was sluggish. We did some digging and ...